Myriad Launches AI Prostate Cancer Test
Myriad Genetics introduces Prolaris + AI for prostate cancer diagnosis, potentially improving treatment outcomes. This may impact healthcare stocks.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.